121532-44-3

Basic information

• Product Name: 1-{[(6aR,9S)-7-methyl-7-oxido-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methyl}imidazolidine-2,4-dione
• CAS NO: 121532-44-3
• Molecular Formula: C₁₉H₂₂N₄O₃
• Molecular Weight: 354.403
• Mol File: 121532-44-3.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: 1-{[(6aR,9S)-7-methyl-7-oxido-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methyl}imidazolidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 1-{[(6aR,9S)-7-methyl-7-oxido-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methyl}imidazolidine-2,4-dione(121532-44-3)
• EPA Substance Registry System: 1-{[(6aR,9S)-7-methyl-7-oxido-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methyl}imidazolidine-2,4-dione(121532-44-3)

Safety Data

• Hazardous Substances Data: 121532-44-3(Hazardous Substances Data)

Usage

Molecular structure

The compound has a complex molecular structure consisting of an indoloquinolin-9-ylmethyl group and an imidazolidine-2,4-dione moiety.

Stereochemistry

The compound has a specific stereochemistry with the 6aR,9S configuration.

Oxidation state

The compound has an oxidized 7-methyl group.

Hydrogen bonding

The compound may have the potential for hydrogen bonding due to the presence of the imidazolidine-2,4-dione moiety.

Solubility

The compound's solubility in various solvents would need to be determined, as it could impact its pharmaceutical applications.

Stability

The compound's stability under different conditions (e.g., temperature, pH) would need to be studied to understand its suitability for drug development.

Pharmacological activity

The compound has potential pharmaceutical applications, but its specific activities and uses would need to be explored further.

Medicinal chemistry

The compound's unique structure and properties may have implications in the field of medicinal chemistry and drug development.

Toxicity

The compound's toxicity and potential side effects would need to be evaluated to ensure its safety for use in pharmaceutical applications.

Synthesis

The synthesis of the compound may involve complex chemical reactions and techniques, which would need to be optimized for large-scale production.

Purity

The purity of the compound would need to be assessed and maintained to ensure its effectiveness and safety in pharmaceutical applications.

Structural analogs

The compound may have structural analogs with similar or different properties, which could be explored for potential applications in drug development.

Patentability

The compound's unique structure may make it eligible for patent protection, which could be valuable for commercialization in the pharmaceutical industry.